SCHEMBL4904407

SCHEMBL4904407

COC(=O)c1cc(S(=O)(=O)NCCOc2ccc(C(C)(C)C)cc2)cc(C)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
LMNA P02545 2/20 0.48
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
CASP3 P42574 1/20 0.41
RAB9A P51151 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
KDM4E B2RXH2 2/20 0.40
MITF O75030 1/20 0.40
GAA P10253 1/20 0.40
GPR35 Q9HC97 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 1/20 0.40
PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903867 0.91 TDP1 (0.46) SMN1; SMN2HTTNPSR1LMNATDP1
SCHEMBL4908583 0.91 HTT (0.48) SMN1; SMN2HTTNPSR1LMNATDP1
SCHEMBL4902606 0.89 TDP1 (0.51) SMN1; SMN2HTTNPSR1LMNATDP1
SCHEMBL4901782 0.88 TDP1 (0.47) HTTNPSR1TDP1ALDH1A1KMT2A
SCHEMBL4906622 0.84 ALDH1A1 (0.46) SMN1; SMN2HTTLMNAALDH1A1KMT2A
SCHEMBL4906225 0.83 NPSR1 (0.46) SMN1; SMN2HTTNPSR1LMNATDP1
SCHEMBL4900998 0.81 TDP1 (0.47) SMN1; SMN2HTTNPSR1LMNATDP1
SCHEMBL6532320 0.81 ALDH1A1 (0.38) SMN1; SMN2HTTLMNAALDH1A1TP53
SCHEMBL4906098 0.81 LMNA (0.54) SMN1; SMN2HTTNPSR1LMNATDP1
SCHEMBL4904258 0.80 TDP1 (0.47) HTTNPSR1LMNATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD SMN1; SMN2 3271/4885HTT 711/4885NPSR1 773/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD SMN1; SMN2 3404/4885HTT 696/4885NPSR1 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.